Search Results for “Customizable SAP E_S4HCON2023 Practice Exam Software 🐂 Easily obtain ➠ E_S4HCON2023 🠰 for free download through ⇛ www.pdfvce.com ⇚ 🛐E_S4HCON2023 Exam Practice” – Page 30

Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey

359

Bygum, A.+, Caballero, T., Grumach, A. S., Longhurst, H. J., Bouillet, L., Aberer, W., Zanichelli, A., Botha, J., Andresen, I., Maurer, M. for the IOS study group: Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the icatibant outcome survey. Clin. Transl. Allergy 2019: 9; 37. IF: 5.13

o.359

128.	Bygum, A., Busse, P., Caballero, T., and Maurer, M.+: Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema. Front. Med. 2017: 4; 212. IF: : 2.03

Diagnosis and treatment of urticaria and angioedema: a worldwide perspective

67.

Sánchez-Borges, M., Asero, R., Ansotegui, I. J., Baiardini, I., Bernstein, J. A., Canonica, G. W., Gower, R., Kahn, D. A., Kaplan, A. P., Katelaris, C., Maurer, M., Sim Park, H., Potter, P., Saini, S., Tassinari, P., Tedeschi, A., Min Ye, Y., Zuberbier, T., and the WAO Scientific and Clinical Issues Council: Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ. J. 2012: 5; 125-147. IF: N/A

r.067

167.	Maltseva, N., Borzova, E., Fomina, D., Bizjak, M., Terhorst-Molawi, D., Košnik, M., Kulthanan, K., Meshkova, R., Thomsen, S. F., and Maurer, M.⁺: Cold urticaria – what we know and what we do not know. Allergy 2021: in press. IF: 14.71

r.167

Urticaria: Collegium Internationale Allergologicum (CIA) update 2020

158.

Maurer, M.⁺, Eyerich, K., Eyerich, S., Ferrer, M., Gutermuth, J., Hartmann, K., Jakob, T., Kapp, A., Kolkhir, P., Larenas-Linnemann, D., Park, H.-S., Pejler, G., Sanchez-Borges, M., Schäkel, K., Simon, D., Simon, H.-U., Weller, K., Zuberbier, T., and Metz, M.: Urticaria: Collegium Internationale Allergologicum (CIA) update 2020. Int. Arch. Allergy Immunol. 2020: 181; 321-333. IF: 2.75

r.158

159.	Saini, S., Shams, M., Bernstein, J. A., and Maurer, M.⁺: Urticaria and Angioedema across the ages. J. Allergy Clin. Immunol. Pract. 2020: 6; 1866-1874. IF: 8.86

r.159

104	Metz, M., Altrichter, S., Ardelean, E., Keßler, B., Krause, K., Magerl, M., Siebenhaar, F., Weller, K., Zuberbier, T., and Maurer, M.+: Anti-immunglobulin E treatment of patients with recalcitrant physical urticaria. Int. Arch. Allergy Immunol. 2011: 154; 177-180. IF: 2.40

206	Hawro, T., Zalewska, A., Hawro, M., Kaszuba, A., Królikowska, M., and Maurer M.+: Impact of psoriasis severity on family income and quality of life. J. Eur. Acad. Dermatol. Venereol. 2015: 29; 438-443. IF: TBD 2.82

Adaptation and initial results of the polish version of the GA²LEN chronic urticaria quality of life questionnaire

106

Brzoza, Z.+, Badura-Brzoza, K., Młynek, A., Magerl, M., Baiardini, I., Canonica, G. W., Weller, K., Kocatürk, E., Kalogeromitros, D., Zalewska-Janowska, A., Zuberbier, T., and Maurer, M.: Adaptation and initial results of the polish version of the GA²LEN chronic urticaria quality of life questionnaire (CU-Q2oL). J. Dermatol. Sci. 2011: 62; 36-41. IF: 3.71

124.	Sánchez-Borges, M., Caballero-Fonseca, F., Capriles-Hulett, A., González-Aveledo, L., and Maurer, M.: Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria. J. Eur. Acad. Dermatol. Venereol. 2017: 31; 964-971. IF: 4.29

r.124

Results